Evidence map›Paper›PMID 30804505›Full record

ArticleNature cell biology2019

Apical-basal polarity inhibits epithelial-mesenchymal transition and tumour metastasis by PAR-complex-mediated SNAI1 degradation.

Hae-Yun Jung, Laurent Fattet, Jeff H Tsai, Taketoshi Kajimoto, Qiang Chang, Alexandra C Newton, Jing Yang

Erratum issuedAbstract read
In one paragraph

Article in Nature cell biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 82 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed, 1 pooled it
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 1 synthesis or guideline pooled it, 134 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Hae-Yun JungDepartment of Pharmacology, Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA.
Laurent FattetDepartment of Pharmacology, Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA.ORCID http://orcid.org/0000-0001-5152-4937
Jeff H TsaiDepartment of Pharmacology, Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA.
Taketoshi KajimotoDepartment of Pharmacology, Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA.
Qiang ChangDepartment of Medical Genetics and Department of Neurology, Waisman Center, University of Wisconsin-Madison, Madison, WI, USA.
Alexandra C NewtonDepartment of Pharmacology, Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA.
Jing YangDepartment of Pharmacology, Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA. jingyang@ucsd.edu.ORCID http://orcid.org/0000-0001-8410-3549
University of California San Diego · USUniversity of Wisconsin–Madison · US

Funding

VIRAL MALIGNANCYP30CA023100 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DIANE M SIMEONE · 1985 to 2026
$124.9M
Project# 4: INTERACTIONS OF ANCHORING PROTEINS WITH THEIR TARGETSP01DK054441 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TAYLOR, SUSAN S. · 1999 to 2017
$27.3M
Molecular Mechanisms of Cell SignalingR35GM122523 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ALEXANDRA C. NEWTON · 2017 to 2026
$6.7M
Regulation of Tumor Invasion and Metastasis by Matrix StiffnessR01CA174869 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Jing Yang · 2015 to 2026
$4.3M
Biomaterial Mimicry of Dynamic Matrix Stiffening During Tumor ProgressionR01CA206880 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ENGLER, ADAM J, YANG, JING · 2016 to 2020
$1.8M
Regulation of Tumor Invasion by Twist1R01CA168689 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI YANG, JING · 2012 to 2016
$1.7M
Dissecting molecular determinants of carcinoma dormancy in vivoR21CA191442 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI YANG, JING · 2015 to 2016
$371k
NCI NIH HHS P30 CA023100NCI NIH HHS R01 CA168689NCI NIH HHS R01 CA174869NCI NIH HHS R01 CA206880NCI NIH HHS R21 CA191442NIDDK NIH HHS P01 DK054441NIGMS NIH HHS R35 GM122523
6 · The paper itself

Abstract

Loss of apical-basal polarity and activation of epithelial-mesenchymal transition (EMT) both contribute to carcinoma progression and metastasis. Here, we report that apical-basal polarity inhibits EMT to suppress metastatic dissemination. Using mouse and human epithelial three-dimensional organoid cultures, we show that the PAR-atypical protein kinase C (aPKC) polarity complex inhibits EMT and invasion by promoting degradation of the SNAIL family protein SNAI1. Under intact apical-basal polarity, aPKC kinases phosphorylate S249 of SNAI1, which leads to protein degradation. Loss of apical-basal polarity prevents aPKC-mediated SNAI1 phosphorylation and stabilizes the SNAI1 protein to promote EMT and invasion. In human breast tumour xenografts, inhibition of the PAR-complex-mediated SNAI1 degradation mechanism promotes tumour invasion and metastasis. Analyses of human breast tissue samples reveal negative correlations between PAR3 and SNAI1 protein levels. Our results demonstrate that apical-basal polarity functions as a critical checkpoint of EMT to precisely control epithelial-mesenchymal plasticity during tumour metastasis.

Indexed as

Cell PolarityEpithelial-Mesenchymal TransitionAdaptor Proteins, Signal TransducingAnimalsCaco-2 CellsCell Cycle ProteinsCell Line, TumorFemaleHumansMembrane ProteinsMice, Inbred BALB CMice, NudeMice, TransgenicMultiprotein ComplexesNeoplasm MetastasisNeoplasmsAdaptor Proteins, Signal TransducingCell Cycle ProteinsMembrane ProteinsMultiprotein ComplexesPARD3 protein, humanPARD6A protein, humanPKC-3 proteinProtein Kinase CSNAI1 protein, humanSnail Family Transcription Factors

Identifiers

PMID30804505
PMCPMC6546105
OpenAlexW2917197748

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.